EyeNet Magazine
Rethinking Mitomycin C
Rethinking Mitomycin C
Tips from glaucoma and refractive surgeons on ways to get the most out of this powerful drug while minimizing complications. (cont.)
 
 
 
 
 
 
 
Mystery Image
Blink
Mystery Image
What do you see?
 
 

Cornea
Demystifying NSAIDs
As bromfenac (Xibrom), a new topical nonsteroidal anti-inflammatory drug, nears FDA approval, ophthalmologists are still sorting out topical NSAIDs’ indications and risk-benefit profiles. (cont.)

 
 
Refractive
Treating LASIK-Induced Aberrations
A decade of success in refractive surgery for myopia has produced an inevitable outcome: exceedingly high expectations. Indeed, 20/20 is no longer good enough.(cont.)
 
 

Advertisers

Advanced Vision Research

 

 

 

Alcon

  Inspire Logo

 

Pfizer-Ophth_web

 

 

 

Citi Heatlh


 

 
About Us Academy Jobs Privacy Policy Contact Us Terms of Service Medical Disclaimer Site Index